Surge in regulatory cells does not prevent onset of hyperglycemia in NOD mice

Autoimmunity

Volumn 47, Issue 2, 2014, Pages 105-112

  Kaminitz, Ayelet ^a   Mizrahi, Keren ^a   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Immune phenotype; Inflammatory insulitis; Mechanisms; NOD mouse; Regulatory T cells

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; INTERLEUKIN 2; LEUKOCYTE ANTIGEN;

AGING; ANIMAL; ARTICLE; BLOOD; CELL CULTURE; CELL MOTION; DRUG EFFECT; FEMALE; GENE EXPRESSION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMMUNOLOGY; IMMUNOPHENOTYPING; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; LYMPHOCYTE COUNT; MESENTERY; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PANCREAS; PATHOLOGY; REGULATORY T LYMPHOCYTE; SEVERITY OF ILLNESS INDEX; THYMUS;

AGING; ANIMALS; ANTIGENS, CD; BLOOD GLUCOSE; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION; HUMANS; HYPERGLYCEMIA; IMMUNOPHENOTYPING; INTERLEUKIN-2; LYMPH NODES; LYMPHOCYTE COUNT; MESENTERY; MICE; MICE, INBRED NOD; PANCREAS; SEVERITY OF ILLNESS INDEX; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND;

EID: 84893748811     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.866103     Document Type: Article

References (64)

1. Gregori, S., N. Giarratana, S. Smiroldo, and L. Adorini. 2003. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol. 171: 4040-4047.
2. You, S., M. Belghith, S. Cobbold, et al. 2005. Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. Diabetes. 54: 1415-1422.
3. Mellanby, R. J., D. Thomas, J. M. Phillips, and A. Cooke. 2007. Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4CD25Foxp3 regulatory T cells. Immunology. 121: 15-28.
4. Serreze, D. V., E. A. Johnson, H. D. Chapman, et al. 2001. Autoreactive diabetogenic T-cells in NOD mice can efficiently expand from a greatly reduced precursor pool. Diabetes. 50: 1992-2000.
5. Schneider, A., M. Rieck, S. Sanda, et al. 2008. The effector T cells of diabetic subjects are resistant to regulation via CD4FOXP3 regulatory T cells. J. Immunol. 181: 7350-7355.
6. Lourenço, E. V., and A. La Cava. 2011. Natural regulatory T cells in autoimmunity. Autoimmunity. 44: 33-42.
7. Yarkoni, S., T. B. Prigozhina, S. Slavin, and N. Askenasy. 2012. IL-2-targeted therapy ameliorates the severity of graft-versus-host disease: Ex vivo selective depletion of host-reactive T cells and in vivo therapy. Biol. Blood Marrow Transplant. 18: 523-535.
8. Wu, A. J., H. Hua, S. H. Munson, and H. O. McDevitt. 2002. Tumor necrosis factor-alpha regulation of CD4CD25 T cell levels in NOD mice. Proc. Natl. Acad. Sci. USA. 99: 12287-12292.
9. Pop, S. M., C. P. Wong, D. A. Culton, et al. 2005. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4CD25 regulatory T cells during autoimmune diabetes. J. Exp. Med. 201: 1333-1346.
10. Alard, P., J. N. Manirarora, S. A. Parnell, et al. 2006. Deficiency in NOD antigen-presenting cell function may be responsible for suboptimal CD4CD25 T-cell-mediated regulation and type 1 diabetes development in NOD mice. Diabetes. 55: 2098-2105.
11. Youngm, E. F., P. R. Hess, L. W. Arnold, et al. 2009. Islet lymphocyte subsets in male and female NOD mice are qualitatively similar but quantitatively distinct. Autoimmunity. 42: 678-691.
12. Tucker, C. F., D. L. Nebane-Ambe, and A. Chhabra. 2011. Decreased frequencies of CD4CD25Foxp3 cells and the potent CD103 subset in peripheral lymph nodes correlate with autoimmune disease predisposition in some strains of mice. Autoimmunity. 44: 453-464.
13. Kukreja, A., G. Cost, J. Marker, et al. 2002. Multiple immunoregulatory defects in type-1 diabetes. J. Clin. Invest. 109: 131-140.
14. Lindley, S., C. M. Dayan, A. Bishop, et al. 2005. Defective suppressor function in CD4CD25 T-cells from patients with type 1 diabetes. Diabetes. 54: 92-99.
15. Putnam, A. L., F. Vendrame, F. Dotta, and P. A. Gottlieb. 2005. CD4CD25high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24: 55-62.
16. Brusko, T., C. Wasserfall, K. McGrail, et al. 2007. No alterations in the frequency of FOXP3 regulatory T-cells in type 1 diabetes. Diabetes. 56: 604-612.
17. Tang, Q., J. Y. Adams, C. Penaranda, et al. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 28: 687-697.
18. Tritt, M., E. Sgouroudis, E. dHennezel, et al. 2008. Functional waning of naturally occurring CD4 regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes. 57: 113-123.
19. Berzins, S. P., E. S. Venanzi, C. Benoist, and D. Mathis. 2003. Tcell compartments of prediabetic NOD mice. Diabetes. 52: 327-334.
20. Nakahara, M., Y. Nagayama, T. Ichikawa, et al. 2011. The effect of regulatory T-cell depletion on the spectrum of organ-specific autoimmune diseases in nonobese diabetic mice at different ages. Autoimmunity. 44: 504-510.
21. Gregg, R. K., R. Jain, S. J. Schoenleber, et al. 2004. A sudden decline in active membrane-bound TGF-beta impairs both T regulatory cell function and protection against autoimmune diabetes. J. Immunol. 173: 7308-7316.
22. Kawamotom, K., A. Pahuja, A. Nettles, et al. 2012. Downregulation of TGF-bRII in T effector cells leads to increased resistance to TGF-b-mediated suppression of autoimmune responses in type I diabetes. Autoimmunity. 45: 310-319.
23. Decallonne, B., E. Van Etten, A. Giulietti, et al. 2003. Defect in activation induced cell death in non-obese diabetic (NOD) T lymphocytes. J. Autoimmun. 20: 219-226.
24. Arreaza, G., K. Salojin, W. Yang, et al. 2003. Deficient activation and resistance to activation-induced apoptosis of CD8 T cells is associated with defective peripheral tolerance in nonobese diabetic mice. Clin. Immunol. 107: 103-115.
25. DAlise, A. M., V. Auyeung, M. Feuerer, et al. 2008. The defect in T-cell regulation in NOD mice is an effect on the T-cell effectors. Proc. Natl. Acad. Sci. USA. 105: 19857-19862.
26. Kaminitz, A., E. S. Yolcu, E. M. Askenasy, et al. 2011. Effector and naturally occurring regulatory T cells display no abnormalities in activation induced cell death in NOD mice. PLoS One. 6: E21630.
27. Yarkoni, S., A. Kaminitz, Y. Sagiv, and N. Askenasy. 2010. Targeting of IL-2 receptor with a caspase fusion protein disrupts autoimmunity in prediabetic and diabetic NOD mice. Diabetologia. 53: 356-368.
28. Kaminitz, A., K. Mizrahi, I. Yaniv, et al. 2009. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice. J. Autoimmun. 33: 83-91.
29. Kaminitz, A., E. S. Yolcu, K. Mizrahi, et al. 2013. Killer Treg cells ameliorate inflammatory insulitis in non-obese diabetic mice through local and systemic immunomodulation. Int. Immunol. 25: 485-494.
30. Kaminitz, A., E. S. Yolcu, J. Stein, et al. 2011. Killer Treg restore immune homeostasis and suppress autoimmune diabetes in prediabetic NOD mice. J. Autoimmun. 37: 39-47.
31. Stephens, L. A., and D. Mason. 2000. CD25 is a marker for CD4 thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25 and CD25-subpopulations. J. Immunol. 165: 3105-3110.
32. Gavin, M. A., S. R. Clarke, E. Negrou, et al. 2002. Homeostasis and anergy of CD4CD25 suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
33. Pedersen, A. E. and J. P. Lauritsen. 2009. CD25 shedding by human natural occurring CD4CD25 regulatory T cells does not inhibit the action of IL-2. Scand. J. Immunol. 70: 40-43.
34. Kaminitz, A., E. M. Askenasy, I. Yaniv, et al. 2010. Apoptosis of purified CD4 T cell subsets is dominated by cytokine deprivation and absence of other cells in new onset diabetic NOD mice. PLoS One. 5: E15684.
35. Askenasy, E. M., and N. Askenasy. 2012. Is autoimmune diabetes caused by aberrant immune activity or defective suppression of physiological self-reactivity Autoimmun. Rev. 12: 633-637.
36. Feuerer, M., W. Jiang, P. D. Holler, et al. 2007. Enhanced thymic selection of FoxP3 regulatory T cells in the NOD mouse model of autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 104: 18181-18186.
37. Tellier, J., A. Andrianjaka, R. Vincente, et al. 2013. Increased thymic development of regulatory T cells in NOD mice is functionally dissociated from type I diabetes susceptibility. Eur. J. Immunol. 43: 1356-1362.
38. Zelenay, S., T. Lopes-Carvalho, I. Caramalho, et al. 2005. Foxp3 CD25-CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA. 102: 4091-4096.
39. Komatsu, N., M. E. Mariotti-Ferrandiz, Y. Wang, et al. 2009. Heterogeneity of natural Foxp3 T cells: A committed regulatory Tcell lineage and an uncommitted minor population retaining plasticity. Proc. Natl. Acad. Sci. USA. 106: 1903-1908.
40. Graham, K. L., B. Krishnamurthy, S. Fynch, et al. 2012. Intra-islet proliferation of cytotoxic T lymphocytes contributes to insulitis progression. Eur. J. Immunol. 42: 1717-1722.
41. Chen, W., W. Jin, N. Hardegen, et al. 2003. Conversion of peripheral CD4CD25-naive T cells to CD4CD25 regulatory T cells by TGF-beta induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
42. Curotto De Lafaille, M. A., A. C. Lino, N. Kutchukhidze, and J. J. Lafaille. 2004. CD25-T cells generate CD25Foxp3 regulatory T cells by peripheral expansion. J. Immunol. 173: 7259-7268.
43. Liang, S., P. Alard, Y. Zhao, et al. 2005. Conversion of CD4 CD25-cells into CD4 CD25 regulatory T cells in vivo requires B7 costimulation, but not the thymus. J. Exp. Med. 201: 127-137.
44. Zhou, X., N. Kong, H. Zou, et al. 2011. Therapeutic potential of TGF-b-induced CD4 Foxp3 regulatory T cells in autoimmune diseases. Autoimmunity. 44: 43-50.
45. Thomas, H. E., K. L. Graham, J. Chee, et al. 2013. Proinflammatory cytokines contribute to development and function of regulatory T cells in type 1 diabetes. Ann. N. Y. Acad. Sci. 1283: 81-86.
46. Yarkoni, S., A. Kaminitz, Y. Sagiv, et al. 2008. Involvement of IL-2 in homeostasis of regulatory T cells: The IL-2 cycle. Bioessays. 30: 875-888.
47. Sgouroudis, E., M. Kornete, and C. A. Piccirillo. 2011. IL-2 production by dendritic cells promotes Foxp3 regulatory T-cell expansion in autoimmune-resistant NOD congenic mice. Autoimmunity. 44: 406-414.
48. Grinberg-Bleyer, Y., A. Baeyens, S. You, et al. 2010. IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells. J. Exp. Med. 207: 1871-1878.
49. Tonkin, D. R., J. He, G. Barbour, and K. Haskins. 2008. Regulatory T cells prevent transfer of type 1 diabetes in NOD mice only when their antigen is present in vivo. J. Immunol. 181: 4516-4522.
50. Yolcu, E. S., S. Ash, A. Kaminitz, et al. 2008. Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression. Immunol. Cell. Biol. 86: 650-658.
51. Pandiyan, P., L. Zheng, S. Ishihara, et al. 2007. CD4 CD25Foxp3 regulatory T cells induce cytokine deprivationmediated apoptosis of effector CD4 T cells. Nat. Immunol. 8: 1353-3162.
52. Kaminitz, A., J. Stein, I. Yaniv, and N. Askenasy. 2007. The vicious cycle of apoptotic beta-cell death in type 1 diabetes. Immunol. Cell. Biol. 85: 582-589.
53. Pandiyan, P., and M. J. Lenardo. 2008. The control of CD4CD25Foxp3 regulatory T cell survival. Biol. Direct. 3
54. doi:10.1186/1745-6150-3-6.
55. Grinberg-Bleyer, Y., D. Saadoun, A. Baeyens, et al. 2010. Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs. J. Clin. Invest. 120: 4558-4568.
56. Billiard, F., E. Litvinova, D. Saadoun, et al. 2006. Regulatory and effector T cell activation levels are prime determinants of in vivo immune regulation. J. Immunol. 177: 2167-2174.
57. Sojka, D. K., C. A. Lazarski, Y. H. Huang, et al. 2009. Regulation of immunity at tissue sites of inflammation. Immunol. Res. 45: 239-250.
58. Askenasy, N., A. Kaminitz, and S. Yarkoni. 2008. Mechanisms of T regulatory cell function. Autoimmun. Rev. 7: 370-375.
59. Vignali, D. A. A. 2012. Mechanisms of Treg suppression: Still a long way to go. Front. Immunol. 3: 191. doi: 10.3389/fimmu.2012.00191.
60. Kornete, M., H. Beauchemin, C. Polychronakos, and C. A. Piccirillo. 2013. Pancreatic islet cell phenotype and endocrine function throughout diabetes development in non-obese diabetic mice. Autoimmunity. 46: 259-268.
61. Delovitch, T. L., and B. Singh. 1997. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD. Immunity. 7: 727-738.
62. Anderson, M. S., and J. A. Bluestone. 2005. The NOD mouse: A model of immune dysregulation. Annu. Rev. Immunol. 23: 447-485.
63. Sgouroudis, E., and C. A. Piccirillo. 2009. Control of type 1 diabetes by CD4Foxp3 regulatory T cells: Lessons from mouse models and implications for human disease. Diabetes Metab. Res. Rev. 25: 208-218.
64. Driver, J. P., D. V. Serreze, and Y. G. Chen. 2011. Mouse models for the study of autoimmune type 1 diabetes: A NOD to similarities and differences to human disease. Semin. Immunopathol. 33: 67-87.